Kinnevik AB's Nomination committee for the 2026 Annual General Meeting

5 September 2025, 8:00 AMRegulatory information

In accordance with the instruction for the Nomination Committee adopted by the 2025 Annual General Meeting in Kinnevik AB (publ) ("Kinnevik"), Cristina Stenbeck has convened a Nomination Committee comprising members appointed by Kinnevik's largest shareholders in terms of voting interest.

The Nomination Committee comprises Cristina Stenbeck (appointed by Verdere S.à r.l., AMS Sapere Aude Trust fbo HS and AMS Sapere Aude Trust fbo SMS), Marie Klingspor (appointed by Wilhelm Klingspor, Amelie Klingspor and herself), Cian Whelan (appointed by Baillie Gifford) and Erik Brändström (appointed by Spiltan Fonder). Marie Klingspor has been appointed Chairperson of the Committee.

Information about the work of the Nomination Committee can be found on Kinnevik's website at www.kinnevik.com. Shareholders wishing to submit proposals to the Nomination Committee can do so in writing to [email protected] or to the Company Secretary, Kinnevik AB, Box 2094, SE-103 13 Stockholm, Sweden.

For further information, visit www.kinnevik.com or contact:

Torun Litzén, Director Investor Relations
Phone +46 (0)70 762 00 50
Email [email protected]

Kinnevik is a leading growth investor on a mission to redefine industries and create remarkable growth companies. We are an active owner and operational partner, providing patient capital to challenger technology-enabled businesses in Europe and the US. Our passionate founders are building tomorrow’s leaders within healthcare, software and climate, making everyday life easier and better for people around the world. We invest at all stages of a company’s growth journey, always determined to create long-term value. Kinnevik was founded in 1936 by the Stenbeck, Klingspor and von Horn families. Kinnevik’s shares are listed on Nasdaq Stockholm’s list for large cap companies under the ticker codes KINV A and KINV B.

Attachments